{"id":82819,"topic":"peptides","source":"businesswire.com","title":"Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes - businesswire.com","url":"https://www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","url_hash":"55eef3817f03eb67655e85e1d7f25728f79e7436","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMijAJBVV95cUxOanJmb3FWY05qdGwxVlZINWtDS3Z6QmVDVkZkV0VaUHBpTUJudHZFLUJWV2Q1ejJlWm1BM2pOU2dhTzVzcEMzWTlRVE9UMDBHc1dMTWRQTzY5Zk9UZXZkSkFvWkxITmJzUUFucjN0VWVKUWpoSkVXZ0JibWJsWjlyakdoZGxDN25HbjdGLVQxc3c3c1Z4bUkxNUtEZHBVOGdkaGNya1BsZTkwZjlnT2hBRGE4SGx5b253d19LZ0tGZzBQMWFTNGY3NnN3MzVwUVJWdVJwSm5RUXlDZDMzM3paeWZUOVNxZ3JTTWRhTlZSOGZhWHR2ODAyeVh5Znl1VDFfTlFkc0N1LW5TSWN0?oc=5\" target=\"_blank\">Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">businesswire.com</font>","content":null,"image_url":null,"lang":"en","published_at":"2026-09-15T11:00:54+00:00","fetched_at":"2026-09-15T11:15:09+00:00","status":"read","starred":0,"extract_state":"failed","summary_auto":null,"cluster_id":null,"extract_retries":2,"extract_error":"http_403","contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":617,"usable_text_length":617,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":617}},"news_item":{"id":82819,"canonical_url":"https://www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","source_url":"https://www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","title":"Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes - businesswire.com","source_name":"businesswire.com","author":null,"published_at":"2026-09-15T11:00:54+00:00","locale":"en","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMijAJBVV95cUxOanJmb3FWY05qdGwxVlZINWtDS3Z6QmVDVkZkV0VaUHBpTUJudHZFLUJWV2Q1ejJlWm1BM2pOU2dhTzVzcEMzWTlRVE9UMDBHc1dMTWRQTzY5Zk9UZXZkSkFvWkxITmJzUUFucjN0VWVKUWpoSkVXZ0JibWJsWjlyakdoZGxDN25HbjdGLVQxc3c3c1Z4bUkxNUtEZHBVOGdkaGNya1BsZTkwZjlnT2hBRGE4SGx5b253d19LZ0tGZzBQMWFTNGY3NnN3MzVwUVJWdVJwSm5RUXlDZDMzM3paeWZUOVNxZ3JTTWRhTlZSOGZhWHR2ODAyeVh5Znl1VDFfTlFkc0N1LW5TSWN0?oc=5\" target=\"_blank\">Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">businesswire.com</font>","full_text":null,"excerpt":"<a href=\"https://news.google.com/rss/articles/CBMijAJBVV95cUxOanJmb3FWY05qdGwxVlZINWtDS3Z6QmVDVkZkV0VaUHBpTUJudHZFLUJWV2Q1ejJlWm1BM2pOU2dhTzVzcEMzWTlRVE9UMDBHc1dMTWRQTzY5Zk9UZXZkSkFvWkxITmJzUUFucjN0VWVKUWpoSkVXZ0JibWJsWjlyakdoZGxDN25HbjdGLVQxc3c3c1Z4bUkxNUtEZHBVOGdkaGNya1BsZTkwZjlnT2hBRGE4SGx5b253d19LZ0tGZzBQMWFTNGY3NnN3MzVwUVJWdVJwSm5RUXlDZDMzM3paeWZUOVNxZ3JTTWRhTlZSOGZhWHR2ODAyeVh5Znl1VDFfTlFkc0N1LW5TSWN0?oc=5\" target=\"_blank\">Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">businesswire.com</font>","extraction":{"state":"failed","confidence":0.0,"error":"http_403","explanation":"Low confidence: HTTP extraction failure (http_403).","diagnostics_url":"/api/diagnose?url=https%3A//www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":617,"usable_text_length":617,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":617}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes - businesswire.com","url":"https://www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","summary":"<a href=\"https://news.google.com/rss/articles/CBMijAJBVV95cUxOanJmb3FWY05qdGwxVlZINWtDS3Z6QmVDVkZkV0VaUHBpTUJudHZFLUJWV2Q1ejJlWm1BM2pOU2dhTzVzcEMzWTlRVE9UMDBHc1dMTWRQTzY5Zk9UZXZkSkFvWkxITmJzUUFucjN0VWVKUWpoSkVXZ0JibWJsWjlyakdoZGxDN25HbjdGLVQxc3c3c1Z4bUkxNUtEZHBVOGdkaGNya1BsZTkwZjlnT2hBRGE4SGx5b253d19LZ0tGZzBQMWFTNGY3NnN3MzVwUVJWdVJwSm5RUXlDZDMzM3paeWZUOVNxZ3JTTWRhTlZSOGZhWHR2ODAyeVh5Znl1VDFfTlFkc0N1LW5TSWN0?oc=5\" target=\"_blank\">Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">businesswire.com</font>","source":"businesswire.com","date":"2026-09-15T11:00:54+00:00","content":"","confidence":0.0,"diagnostics_url":"/api/diagnose?url=https%3A//www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","quality_bucket":"failed","failure_kind":"http","retryable":false,"quality_reason":"Low confidence: HTTP extraction failure (http_403).","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":617,"usable_text_length":617,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":617}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/82819","export_markdown":"/api/items/82819/export?format=markdown","export_json":"/api/items/82819/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes"},"formats":{"full":{"id":82819,"title":"Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes - businesswire.com","url":"https://www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","source":"businesswire.com","author":null,"published_at":"2026-09-15T11:00:54+00:00","locale":"en","topic":"peptides","tags":[],"excerpt":"<a href=\"https://news.google.com/rss/articles/CBMijAJBVV95cUxOanJmb3FWY05qdGwxVlZINWtDS3Z6QmVDVkZkV0VaUHBpTUJudHZFLUJWV2Q1ejJlWm1BM2pOU2dhTzVzcEMzWTlRVE9UMDBHc1dMTWRQTzY5Zk9UZXZkSkFvWkxITmJzUUFucjN0VWVKUWpoSkVXZ0JibWJsWjlyakdoZGxDN25HbjdGLVQxc3c3c1Z4bUkxNUtEZHBVOGdkaGNya1BsZTkwZjlnT2hBRGE4SGx5b253d19LZ0tGZzBQMWFTNGY3NnN3MzVwUVJWdVJwSm5RUXlDZDMzM3paeWZUOVNxZ3JTTWRhTlZSOGZhWHR2ODAyeVh5Znl1VDFfTlFkc0N1LW5TSWN0?oc=5\" target=\"_blank\">Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">businesswire.com</font>","full_text":null,"reading_time_min":1,"extraction":{"state":"failed","confidence":0.0,"error":"http_403","explanation":"Low confidence: HTTP extraction failure (http_403).","diagnostics_url":"/api/diagnose?url=https%3A//www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":617,"usable_text_length":617,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":617}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":617,"usable_text_length":617,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":617}},"actions":{"read":"/item/82819","export_markdown":"/api/items/82819/export?format=markdown","export_json":"/api/items/82819/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes"}},"digest":{"id":82819,"title":"Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes - businesswire.com","url":"https://www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","source":"businesswire.com","topic":"peptides","published_at":"2026-09-15T11:00:54+00:00","excerpt":"<a…","quality_bucket":"failed","quality_reason":"Low confidence: HTTP extraction failure (http_403).","reading_time_min":1,"cluster_id":null},"card":{"display_title":"Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes - businesswire.com","subtitle":"businesswire.com · 2026-09-15","summary":"<a…","badges":["quality:failed","issue:http"],"links":{"read":"/item/82819","original":"https://www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","diagnose":"/api/diagnose?url=https%3A//www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes"},"quality_warning":"Low confidence: HTTP extraction failure (http_403)."},"export":{"title":"Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes - businesswire.com","url":"https://www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","summary":"<a href=\"https://news.google.com/rss/articles/CBMijAJBVV95cUxOanJmb3FWY05qdGwxVlZINWtDS3Z6QmVDVkZkV0VaUHBpTUJudHZFLUJWV2Q1ejJlWm1BM2pOU2dhTzVzcEMzWTlRVE9UMDBHc1dMTWRQTzY5Zk9UZXZkSkFvWkxITmJzUUFucjN0VWVKUWpoSkVXZ0JibWJsWjlyakdoZGxDN25HbjdGLVQxc3c3c1Z4bUkxNUtEZHBVOGdkaGNya1BsZTkwZjlnT2hBRGE4SGx5b253d19LZ0tGZzBQMWFTNGY3NnN3MzVwUVJWdVJwSm5RUXlDZDMzM3paeWZUOVNxZ3JTTWRhTlZSOGZhWHR2ODAyeVh5Znl1VDFfTlFkc0N1LW5TSWN0?oc=5\" target=\"_blank\">Elvinix Secures Exclusive License to Advance Novel Peptide Therapy Aimed at Restoring Insulin Production in Type 1 Diabetes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">businesswire.com</font>","source":"businesswire.com","date":"2026-09-15T11:00:54+00:00","content":"","confidence":0.0,"diagnostics_url":"/api/diagnose?url=https%3A//www.businesswire.com/news/home/20260915187568/en/Elvinix-Secures-Exclusive-License-to-Advance-Novel-Peptide-Therapy-Aimed-at-Restoring-Insulin-Production-in-Type-1-Diabetes","quality_bucket":"failed","failure_kind":"http","retryable":false,"quality_reason":"Low confidence: HTTP extraction failure (http_403).","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":617,"usable_text_length":617,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":617}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}